Terms: = Colorectal cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Treatment
8 results:
1. The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.
Bissonnette RP; Cesario RM; Goodenow B; Shojaei F; Gillings M
BMC Cancer; 2021 Aug; 21(1):969. PubMed ID: 34461854
[TBL] [Abstract] [Full Text] [Related]
2. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
[TBL] [Abstract] [Full Text] [Related]
3. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/tnfaip3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract] [Full Text] [Related]
4. TNFα induces tolerant production of CXC chemokines in colorectal cancer HCT116 cells via a20 inhibition of ERK signaling.
Zhou X; An D; Liu X; Jiang M; Yuan C; Hu J
Int Immunopharmacol; 2018 Jan; 54():296-302. PubMed ID: 29175508
[TBL] [Abstract] [Full Text] [Related]
5. Sulindac activates NF-κB signaling in colon cancer cells.
Mladenova D; Pangon L; Currey N; Ng I; Musgrove EA; Grey ST; Kohonen-Corish MR
Cell Commun Signal; 2013 Oct; 11():73. PubMed ID: 24083678
[TBL] [Abstract] [Full Text] [Related]
6. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.
Hemmerle T; Neri D
Int J Cancer; 2014 Jan; 134(2):467-77. PubMed ID: 23818211
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells.
Collett GP; Campbell FC
Carcinogenesis; 2006 Jun; 27(6):1285-91. PubMed ID: 16497702
[TBL] [Abstract] [Full Text] [Related]
8. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
Adams S; Miller GT; Jesson MI; Watanabe T; Jones B; Wallner BP
Cancer Res; 2004 Aug; 64(15):5471-80. PubMed ID: 15289357
[TBL] [Abstract] [Full Text] [Related]
